You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Live chat

Stay informed

Request a contact

Supply availability

GSK's medicines and vaccines supply availability

For information about our current UK supply availability, please select the link below.

Current UK supply (PDF)

 

Distribution model change

GSK UK Pharmaceuticals and ViiV Healthcare are changing the way we distribute medicines and vaccines in the UK from the current direct to pharmacy model to a reduced wholesaler model. The change will take place on the 1st November 2018.
Please see the below appropriate attachment for more info.

General letter

Boots letter

Boostrix-IPV (Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)) will be available to order from the end of February 2019

Click here to order vaccines online

Note : Vaccines for the UK national immunisation programme should be ordered as normal via Immform

Prescribing Information

Divested and discontinued products

Discontinued:

> Hepatyrix vaccines PFS

> Typherix vaccines PFS

Divested:

> Trimovate cream 30gm - divested to Ennogen Healthcare

> Warticon cream 0.15% - divested to Pheonix Labs

> Warticon solution 0.5% - divested to Phoenix Labs

Vaccines supply

For frequently asked questions about the supply of our vaccines including the Hepatitis B supply management process.

Download PDF

What causes vaccines shortages?

Video player requires JavaScript enabled. You can download this video here: https://gskvideo.edgesuite.net/HealthSites/Health/UK/MP4/Vaccines-Supply-Video.mp4

Further information

If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com); Freephone: 0800 221 441 or chat to a member of our team online.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.